VISTA antagonist and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10933115
APP PUB NO 20160331803A1
SERIAL NO

15111550

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to a peptide, multimer, conjugate, analog, derivative or mimetic thereof that inhibits the activity of VISTA. The invention further contemplates therapeutic use of the VISTA antagonist peptide, multimer, conjugate, derivative or mimetic thereof, including treating or preventing cancer, bacterial infections, viral infections, parasitic infections and fungal infections, as well as research uses of the antagonist.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE TRUSTEES OF DARTMOUTH COLLEGE; KING'S GOLLEGE LONDON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ceeraz, Sabrina Lebanon, US 10 169
Lemercier, Isabelle Enfield, US 17 186
Lines, Janet London, GB 10 169
Noelle, Randolph J Plainfield, US 80 1338
Nowak, Elizabeth West Lebanon, US 29 549
Spaller, Mark Lebanon, US 9 74
Wang, Li Norwich, US 972 6677

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 2, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 2, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00